Health CEO demonstrates getting injectable HIV preventive drug Yeztugo
|
The Food and Drug Administration approved the twice-a-year
HIV preventive drug lenacapavir. Gilead will market the drug under the
brand name ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.